PDRX vs ABBV: Which Stock is Better?

Side-by-side comparison of Pd-Rx Pharmaceutical and Abbvie Inc in 2026

Comparison Updated:

PDRX

Pd-Rx Pharmaceutical

$3.35

ABBV

Abbvie Inc

$208.38

Key Metrics Comparison

MetricPDRXABBVWinner
Market Cap$5.75M$369.65BABBV
P/E Ratio3.1088.56PDRX
EPS (TTM)$1.08$2.36ABBV
Revenue Growth-0.0%0.1%ABBV
Gross Margin29.6%71.6%ABBV

Analyze PDRX

Full quant analysis

Analyze ABBV

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is PDRX or ABBV a better investment?

Comparing PDRX and ABBV: Pd-Rx Pharmaceutical has a market cap of $5.75M while Abbvie Inc has $369.65B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between PDRX and ABBV?

PDRX (Pd-Rx Pharmaceutical) and ABBV (Abbvie Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: PDRX or ABBV?

Based on P/E ratios, PDRX trades at a lower multiple (3.1x vs 88.6x).

Which is growing faster: PDRX or ABBV?

ABBV has higher revenue growth at 0.1% vs -0.0% for PDRX.

Which company is more profitable: PDRX or ABBV?

Abbvie Inc (ABBV) has higher gross margins at 71.6% compared to 29.6% for PDRX.

Which is the larger company: PDRX or ABBV?

Abbvie Inc (ABBV) is larger with a market cap of $369.65B compared to $5.75M for PDRX.

Should I buy PDRX or ABBV in 2026?

Both PDRX and ABBV have investment merit. PDRX trades at $3.35 while ABBV trades at $208.38. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between PDRX and ABBV stock?

Key differences: Market Cap ($5.75M vs $369.65B), P/E Ratio (3.1x vs 88.6x), Revenue Growth (-0.0% vs 0.1%), Gross Margin (29.6% vs 71.6%).

Popular Stock Comparisons